BioSpace News Archive

Astellas again ranked among the top companies for working parents in Working Mother Magazine’s 2020 “100 Best Companies” list for both working mothers and working dads.

Teams from Colombia, Uganda and the U.S. selected for outstanding innovations that help meet need for clean water and adequate food supply globally

Polydex Pharmaceuticals Limited (Pink Sheets:POLXF) (the “Company”) is pleased to report financial results for the second quarter of fiscal 2021, the period ending July 31, 2020. All figures are reported in U.S. dollars. Q2 ending July 31, 2020 Q2 ending July 31, 2019 Sales 1,377,747 1,243,883 Net Income 64,462 119,894 Income per common share - basic 0.02 0.04

Strengthened financial position during H1 2020 with drawdown of IPF loan of EUR 10 million and a capital raise of EUR 17.7 million Imeglimin New Drug Application in Japan (J-NDA) was submitted for the treatment of type 2 diabetes in Q3 2020 and a target launch is expected in 2021 1 ; a milestone payment of EUR 4 million was received in Q3 2020 from Sumitomo Dainippon Pharma Initiated PXL065 Phase 2 trial in biopsy-proven NASH patients i

Newomics Inc., a commercial-stage biotechnology company that sells and develops mass spectrometry products and services, today announced that its award-winning multinozzle emitters (Newomics® M3 emitters) were featured in two publications from Regeneron Pharmaceuticals Inc. and the University of Lausanne, respectively.

The annual event, which convenes thousands of independent community pharmacies, moves to an immersive virtual environment on AmerisourceBergenLive.com

Transaction Supports NorthStar’s Growth in Core Markets and Surgery Partners’ Continued Focus on Its Core Short-Stay Surgical Business [15-September-2020] IRVING, Texas , Sept. 15, 2020 /PRNewswire/ -- NorthStar Anesthesia (“NorthStar” or the “Company”), one of the country’s leading anesthesia care providers and managers, today announced that Anesthesia Consulting

Minimizing the risk of infection for patients and staff is our top priority here at Gibson Diagnostic Labs. To effectively do so in the healthcare world requires facility readiness and workforce availability.

Transparency Market Research has published a new report titled ‘Surgical Glue Market ’. According to the report, the global surgical glue market was valued at approximately ~US$ 1.8 Bn in 2018.

According to the report, the optic nerve disorders treatment market was valued at approximately ~US$ 14.1 Bn in 2018.